8086.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 08:15):

Stats
Dagens volum	421 300
Gjennomsnittsvolum	609 052
Markedsverdi	205.17B
EPS	¥0 ( 2024-02-07 )
Neste inntjeningsdato	( ¥14.64 ) 2024-05-08
Last Dividend	¥8.50 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	22.61
ATR14	¥0.557 (0.04%)

Volum Korrelasjon

Lang: -0.24 (neutral)

Kort: -0.68 (moderate negative)

Signal:(26.306) Neutral

Nipro Corporation Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Nipro Corporation Korrelasjon - Valuta/Råvare

0.50
( neutral )

0.51
( weak )

0.34
( neutral )

-0.24
( neutral )

0.50
( neutral )

Nipro Corporation Økonomi

Annual	2022
Omsetning:	¥545.20B
Bruttogevinst:	¥163.45B (29.98 %)
EPS:	¥28.04

FY	2022
Omsetning:	¥545.20B
Bruttogevinst:	¥163.45B (29.98 %)
EPS:	¥28.04

FY	2022
Omsetning:	¥494.79B
Bruttogevinst:	¥149.27B (30.17 %)
EPS:	¥82.50

FY	2021
Omsetning:	¥455.56B
Bruttogevinst:	¥138.84B (30.48 %)
EPS:	¥87.12

Financial Reports:

No articles found.

Nipro Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥13.50 (N/A)	¥0 (N/A)	¥8.50 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nipro Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 7.70 - good (77.02%) | Divividend Growth Potential Score: 3.48 - Decrease likely (30.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥8.75	2001-03-27
Last Dividend	¥8.50	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	45	--
Total Paid Out	¥561.75	--
Avg. Dividend % Per Year	0.00%	--
Score	3.13	--
Div. Sustainability Score	7.70
Div.Growth Potential Score	3.48
Div. Directional Score	5.59	--

Next Divdend (Est)
(2024-07-18)

¥0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

3.13

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8168.T	Ex Dividend Junior	2024-02-28	Semi-Annually	0.00%
7545.T	Ex Dividend Knight	2024-02-19	Semi-Annually	0.00%
6755.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6098.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4801.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
4023.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3232.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
2264.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
9757.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
8818.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0177	1.500	9.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00921	1.200	9.69	10.00	[0 - 0.3]
returnOnEquityTTM	0.0455	1.500	-0.605	-0.908	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.495	0.800	7.52	6.02	[1 - 3]
quickRatioTTM	0.717	0.800	-0.486	-0.389	[0.8 - 2.5]
cashRatioTTM	0.222	1.500	9.88	10.00	[0.2 - 2]
debtRatioTTM	0.539	-1.500	1.023	-1.534	[0 - 0.6]
interestCoverageTTM	4.49	1.000	9.45	9.45	[3 - 30]
operatingCashFlowPerShareTTM	686.29	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	686.29	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	2.46	-1.500	0.157	-0.236	[0 - 2.5]
grossProfitMarginTTM	0.300	1.000	8.33	8.33	[0.2 - 0.8]
operatingProfitMarginTTM	0.0466	1.000	-1.069	-1.069	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.187	1.000	-0.0728	-0.0728	[0.2 - 2]
assetTurnoverTTM	0.520	0.800	9.87	7.89	[0.5 - 2]
Total Score				7.70

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.11	1.000	8.07	0	[1 - 100]
returnOnEquityTTM	0.0455	2.50	-0.389	-0.908	[0.1 - 1.5]
freeCashFlowPerShareTTM	686.29	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.979	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	686.29	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-3.79	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.194	1.000	7.66	0	[0.1 - 0.5]
Total Score				3.48

Nipro Corporation

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.